Center of Biomolecular Therapy and Diagnostics (CBTD), Faculty of Associated Medical Sciences, Chiang Mai University

March 15, 2025
Chiang Mai University

Center of Biomolecular Therapy and Diagnostics (CBTD), Faculty of Associated Medical Sciences, Chiang Mai University For more details, please visit their:Official website: https://research.ams.cmu.ac.th/site/article?id=211Facebook page: – Facebook Twitter Line

Enhancing T cell cytotoxicity in multiple myeloma with bispecific αPD-L1 × αCD3 T cell engager-armed T cells and low-dose bortezomib therapy

January 31, 2025
Chiang Mai University, Mahidol University

• Researchers have developed a new drug called αPD-L1 × αCD3 BIPE that helps the immune system better target and kill non-small cell lung cancer cells by connecting cancer-fighting...

Novel B7-H3 CAR T cells show potent antitumor effects in glioblastoma: a preclinical study

January 25, 2025
Chulalongkorn University

Researchers from Chulalongkorn University have developed a new weapon against glioblastoma, a notoriously difficult-to-treat brain cancer, in the form of a brand-new antibody. This antibody is a key component...

The 29th Annual Meeting of Japanese Association of Cancer Immunology

January 25, 2025
Chiang Mai University, Chulalongkorn University, Events, Khonkaen University, Mahidol University, Prince of Songkla University

Nagoya, Japan – The Japanese Association of Cancer Immunology (JACI) will host its 29th Annual Meeting from July 24th-26th, 2025, at WINC AICH, Nagoya, Japan. This marks the first...

New Immune Cell Therapy Designed to Improve Treatment for Multiple Myeloma

January 13, 2025
Mahidol University

Researchers have developed a new method to treat multiple myeloma, a type of blood cancer. They engineered a type of immune cell called T cells to produce and release...

New Immune Cell Engager Combined with Chemotherapy Boosts Attack on Multiple Myeloma

January 13, 2025
Chiang Mai University, Mahidol University

Researchers are exploring a new treatment strategy for multiple myeloma, a type of blood cancer that often becomes resistant to therapy. They found that a low dose of the...

A Trispecific Antibody Induces Potent Tumor-Directed T-Cell Activation and Antitumor Activity by CD3/CD28 Co-Engagement

January 10, 2025
Member Content

Recorded VDO

Enhancing Therapeutic Antibody Design with Computational Tools

January 7, 2025
Chiang Mai University

Scientists are using advanced computer programs to design better therapeutic antibodies. These antibodies are crucial for treating various diseases, but sometimes, the patient’s body sees them as foreign and...

Optimizing Humanness of Therapeutic Antibodies

January 7, 2025
Chiang Mai University

Scientists have been working to improve therapeutic antibodies, which are important tools for treating diseases like cancer and autoimmune disorders. A key challenge is making these antibodies less likely...

Prince Mahidol Award Youth Program (PMAYP) Conference 2025

December 27, 2024
Chiang Mai University, Chulalongkorn University, Events, Khonkaen University, Mahidol University, Prince of Songkla University

Prince Mahidol Award Youth Program Conference 2025 Focuses on Immunotherapy in Solid TumorsBangkok, Thailand The Prince Mahidol Award Youth Program Conference 2025 will take place on January 28, 2025,...